MS
GSK icon

Maven Securities’s GSK GSK Stock Holding History

Maven Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,600
Closed -$691K – 125
2018
Q3 		$691K Hold
13,600
– – 0.25% 86
2018
Q2 		$696K Buy
+13,600
New +$685K 0.39% 44
2018
Q1 		– Sell
-9,600
Closed -$435K – 74
2017
Q4 		$435K Buy
+9,600
New +$443K 0.22% 40
2017
Q1 		– Sell
-12,000
Closed -$584K – 54
2016
Q4 		$584K Buy
+12,000
New +$593K 0.52% 22

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Maven Securities's GSK Position: Q4 2018 in Review

Maven Securities sold out of GSK (GSK) in Q4 2018, closing a stake of 13,600 shares — an estimated $691K sold.

Maven Securities first reported a position in GSK in Q4 2016 and held it in 4 quarters. The position peaked at $696K in Q2 2018. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Maven Securities reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • Maven Securities sold 13,600 GSK shares in Q4 2018, an estimated $691K.
  • Maven Securities first reported a position in GSK in Q4 2016 and held it in 4 quarters.
  • Maven Securities's GSK position peaked at $696K in Q2 2018.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Maven Securities's 13F filing for Q4 2018, filed 14 Feb 2019.